Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders


Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s):  MBGNF

Med Biogene Inc is a development stage life science company. The Company is engaged in the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer.
Price: $0.075 | Change: $-0.005 | %Change: -6.25%
Volume: 29,380 | Day High/Low: 0.075/0.07 | 52 Week High/Low: 0.11/0.03
View modes: 
0 stars

Hmmmm I wonder

How many shares WJ and management sold today......????  How about NONE!!!!  rate and reply
0 stars


Someone just sold 1000 shares to get it to 0.07 ...desperate or what.. I have a funny feeling those who are selling will regret it  rate and reply
0 stars

What's the fuss?

seriously, I can only see positives so far coming out from Team WJ and Team NC. Now we also have Team RP to bring in serious long term investors to reduce flippers as we ascend. As usual Team BB more
0 stars

Serious Now

It's not bad, I'm actually excited, I can wait another few months for $$$$$$$. With these things you have to get in early or you miss the boat  rate and reply
0 stars

I can't wait for the big SELL OFF

chance to grab more cheap shares  rate and reply
0 stars

RE:RE:RE:RE:IR Resource

Time to un-pack and analyze again. I do see and understand the frustrations of those on this board. Hear me out before you respond. The February NR The February NR talked about commercialization more
0 stars

I think I'm pulling out

It's always the same, the date gets bumped. I've tied up money on this one for far to long.  rate and reply
0 stars

RE:RE:RE:IR Resource

I'm going to post a fuller reply and analysis later tonight, but I am leaving some highlighted quotes from the February NR here for thought. Med BioGene Inc. ("MBI" or the "Company") (TSX more
1 star

RE:RE:IR Resource

really disappointed in WJ here. What happened to full communication with shareholder? How can you share a significant delay through a fact sheet instead of a NR explaining the delay. The primary more
2.5 stars

RE:IR Resource

After reviewing the hand-out I agree with you Westcoast.  Looks like someone else to deal with shareholders until some better news to share in Q4.  rate and reply
2.5 stars

IR Resource

remind me again the reason for hiring an IR Resource for 6 months when no ccommercialization/sales until 2016? A one/two punch to the hopes of any good price movement last two days. Wow.  rate and reply
3 stars

Fact Sheet

So looks like milestone payments that could have come in Q2 this yr (mentioned in Feb 3rd update) have been pushed out to Q1/Q2 next yr. No potential payers signed on as mentioned in Feb 3 more
1 star

Fact sheet posted on MBI SITE  rate and reply
0 stars

Share holder dividend. Fact sheet

Med BioGene Inc. MBI-TSX Venture Q2 2015  New management team led by proactive shareholder focused on dividend payment   more
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:New Appointment.. Just a FYI

I think WJ deserve credit for sound management by bringing on an IR at this stage of the game when he obviously has significant news to share leading up to full commercialization and what better more
0 stars

RE:MBI Technology

pretty sure it's the only test of its kind for NSCLC. If u know of any other, please post them.  rate and reply
0 stars

MBI Technology

Dont know this story that well, but i have heard there are a few other companies out there that have technology better than MBI. Any of the brains on this board care to enlighten me? Why is their more
3 stars

Like where this is going

I don't post often, but I thought if put in my 2 cents. Being a senior Mktg exec for a Dow Ind. Company, this is exactly what we need to see next...I am a shareholder. Any news will be more
0 stars

RE:RE:RE:RE:RE:RE:RE:New Appointment.. Just a FYI

The point isn't to tell the story to shops which are already familiar with MBI.  The point is to broaden the reach *and* to have a solid story and forecast to share.   Good IR gets the story in more
0 stars

RE:RE:RE:RE:RE:RE:New Appointment.. Just a FYI

Schiff, in theory this may be a good idea. In practice, not so sure. Look at what happened to the sp last time this resource was hired in very similar terms by EB. I still think that payor more